Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 266

1.

Skin sparing mastectomy and robotic latissimus dorsi-flap reconstruction through a single incision.

Houvenaeghel G, Bannier M, Rua S, Barrou J, Heinemann M, Lambaudie E, Cohen M.

World J Surg Oncol. 2019 Nov 2;17(1):176. doi: 10.1186/s12957-019-1711-8.

2.

Robotic breast and reconstructive surgery: 100 procedures in 2-years for 80 patients.

Houvenaeghel G, Bannier M, Rua S, Barrou J, Heinemann M, Knight S, Lambaudie E, Cohen M.

Surg Oncol. 2019 Dec;31:38-45. doi: 10.1016/j.suronc.2019.09.005. Epub 2019 Sep 10. Review.

PMID:
31526915
3.

Transperitoneal para-aortic lymphadenectomy by robot assisted laparoscopy in 10 steps.

Heinemann M, Masquin I, Blache G, Sabiani L, Jauffret C, Houvenaeghel G, Lambaudie E.

J Gynecol Oncol. 2019 Sep;30(5):e74. doi: 10.3802/jgo.2019.30.e74.

4.

Prediction of early discharge after gynaecological oncology surgery within ERAS.

Lambaudie E, Mathis J, Zemmour C, Jauffret-Fara C, Mikhael ET, Pouliquen C, Sabatier R, Brun C, Faucher M, Mokart D, Houvenaeghel G.

Surg Endosc. 2019 Jul 15. doi: 10.1007/s00464-019-06974-w. [Epub ahead of print]

PMID:
31309314
5.

Stem Cells Inhibition by Bevacizumab in Combination with Neoadjuvant Chemotherapy for Breast Cancer.

Sabatier R, Charafe-Jauffret E, Pierga JY, Curé H, Lambaudie E, Genre D, Houvenaeghel G, Viens P, Ginestier C, Bertucci F, Sfumato P, Extra JM, Gonçalves A.

J Clin Med. 2019 May 6;8(5). pii: E612. doi: 10.3390/jcm8050612.

6.

Positive or close margins: reoperation rate and second conservative resection or total mastectomy?

Houvenaeghel G, Lambaudie E, Bannier M, Rua S, Barrou J, Heinemann M, Buttarelli M, Thomassin Piana J, Cohen M.

Cancer Manag Res. 2019 Mar 28;11:2507-2516. doi: 10.2147/CMAR.S190852. eCollection 2019.

7.

Tubular and mucinous breast cancer: results of a cohort of 917 patients.

Roux P, Knight S, Cohen M, Classe JM, Mazouni C, Chauvet MP, Reyal F, Colombo PE, Jouve E, Chopin N, Daraï E, Coutant C, Lambaudie E, Houvenaeghel G.

Tumori. 2019 Feb;105(1):55-62. doi: 10.1177/0300891618811282. Epub 2018 Dec 20.

PMID:
30900967
8.

Preoperative Breast Magnetic Resonance Imaging in Women With Local Ductal Carcinoma in Situ to Optimize Surgical Outcomes: Results From the Randomized Phase III Trial IRCIS.

Balleyguier C, Dunant A, Ceugnart L, Kandel M, Chauvet MP, Chérel P, Mazouni C, Henrot P, Rauch P, Chopier J, Zilberman S, Doutriaux-Dumoulin I, Jaffre I, Jalaguier A, Houvenaeghel G, Guérin N, Callonnec F, Chapellier C, Raoust I, Mathieu MC, Rimareix F, Bonastre J, Garbay JR.

J Clin Oncol. 2019 Apr 10;37(11):885-892. doi: 10.1200/JCO.18.00595. Epub 2019 Feb 27.

PMID:
30811290
9.

Adjuvant chemotherapy in lobular carcinoma of the breast: a clinicopathological score identifies high-risk patient with survival benefit.

de Nonneville A, Jauffret C, Gonçalves A, Classe JM, Cohen M, Reyal F, Mazouni C, Chauvet MP, Chopin N, Colombo PE, Jouve E, Darai E, Rouzier R, Coutant C, Gimbergues P, Azuar AS, de Lara CT, Lambaudie E, Houvenaeghel G.

Breast Cancer Res Treat. 2019 Jun;175(2):379-387. doi: 10.1007/s10549-019-05160-9. Epub 2019 Feb 13.

PMID:
30759288
10.

Breast cancer robotic nipple sparing mastectomy: evaluation of several surgical procedures and learning curve.

Houvenaeghel G, Bannier M, Rua S, Barrou J, Heinemann M, Van Troy A, Lambaudie E, Cohen M.

World J Surg Oncol. 2019 Feb 6;17(1):27. doi: 10.1186/s12957-019-1567-y.

11.

Lymph node positivity in different early breast carcinoma phenotypes: a predictive model.

Houvenaeghel G, Lambaudie E, Classe JM, Mazouni C, Giard S, Cohen M, Faure C, Charitansky H, Rouzier R, Daraï E, Hudry D, Azuar P, Villet R, Gimbergues P, Tunon de Lara C, Martino M, Fraisse J, Dravet F, Chauvet MP, Boher JM.

BMC Cancer. 2019 Jan 10;19(1):45. doi: 10.1186/s12885-018-5227-3.

12.

Overview of the pathological results and treatment characteristics in the first 1000 patients randomized in the SERC trial: axillary dissection versus no axillary dissection in patients with involved sentinel node.

Houvenaeghel G, Cohen M, Raro P, De Troyer J, de Lara CT, Gimbergues P, Gauthier T, Faure-Virelizier C, Vaini-Cowen V, Lantheaume S, Regis C, Darai E, Ceccato V, D'Halluin G, Del Piano F, Villet R, Jouve E, Beedassy B, Theret P, Gabelle P, Zinzindohoue C, Opinel P, Marsollier-Ferrer C, Dhainaut-Speyer C, Colombo PE, Lambaudie E, Tallet A, Boher JM; Others investigators (SERC trial group).

BMC Cancer. 2018 Nov 21;18(1):1153. doi: 10.1186/s12885-018-5053-7.

13.

Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study.

Classe JM, Loaec C, Gimbergues P, Alran S, de Lara CT, Dupre PF, Rouzier R, Faure C, Paillocher N, Chauvet MP, Houvenaeghel G, Gutowski M, De Blay P, Verhaeghe JL, Barranger E, Lefebvre C, Ngo C, Ferron G, Palpacuer C, Campion L.

Breast Cancer Res Treat. 2019 Jan;173(2):343-352. doi: 10.1007/s10549-018-5004-7. Epub 2018 Oct 20.

PMID:
30343457
14.

[...Robotic-assisted latissimus dorsi muscle harvest for immediate breast reconstruction].

Pacelli J, Sharifzadehgan S, Rua S, Houvenaeghel G, Ngo C, Bats AS, Lécuru F, Delomenie M.

Gynecol Obstet Fertil Senol. 2018 Nov;46(10-11):744-746. doi: 10.1016/j.gofs.2018.08.002. Epub 2018 Sep 28. French. No abstract available.

PMID:
30274875
15.

Pelvic exenterations for gynecologic cancers: A retrospective analysis of a 30-year experience in a cancer center.

Knight S, Lambaudie E, Sabiani L, Mokart D, Provansal M, Tallet A, Houvenaeghel G.

Eur J Surg Oncol. 2018 Dec;44(12):1929-1934. doi: 10.1016/j.ejso.2018.08.017. Epub 2018 Sep 3.

PMID:
30262326
16.

Enhanced recovery after surgery program in older patients undergoing gynaecologic oncological surgery is feasible and safe.

de Nonneville A, Jauffret C, Braticevic C, Cecile M, Faucher M, Pouliquen C, Houvenaeghel G, Lambaudie E.

Gynecol Oncol. 2018 Dec;151(3):471-476. doi: 10.1016/j.ygyno.2018.09.017. Epub 2018 Sep 21.

PMID:
30249528
17.

Isolated ipsilateral local recurrence of breast cancer: predictive factors and prognostic impact.

Houvenaeghel G, de Nonneville A, Cohen M, Classe JM, Reyal F, Mazouni C, Chopin N, Martinez A, Daraï E, Coutant C, Colombo PE, Gimbergues P, Chauvet MP, Azuar AS, Rouzier R, de Lara CT, Muracciole X, Agostini A, Gonçalves A, Lambaudie E.

Breast Cancer Res Treat. 2019 Jan;173(1):111-122. doi: 10.1007/s10549-018-4944-2. Epub 2018 Sep 20.

PMID:
30238274
18.

Can we use robotic surgery for the treatment of pelvic recurrence and locally advanced tumors in gynecological surgery?

Blache G, Jauffret C, Mathis J, Knight S, Houvenaeghel G, Lambaudie E.

J Gynecol Obstet Hum Reprod. 2018 Nov;47(9):431-435. doi: 10.1016/j.jogoh.2018.08.008. Epub 2018 Aug 24.

PMID:
30149209
19.

Contribution of intraoperative radiotherapy (IORT) for therapeutic de-escalation in early breast cancer: Report of a single institution's experience.

Barrou J, Tallet A, Cohen M, Bannier M, Buttarelli M, Gonzague L, Jauffret C, Lambaudie E, Rua S, Tyran M, Varela L, Houvenaeghel G.

Breast J. 2018 Sep;24(5):715-723. doi: 10.1111/tbj.12993. Epub 2018 Jan 22.

PMID:
29356235
20.

Enhanced recovery after surgery program in Gynaecologic Oncological surgery in a minimally invasive techniques expert center.

Lambaudie E, de Nonneville A, Brun C, Laplane C, N'Guyen Duong L, Boher JM, Jauffret C, Blache G, Knight S, Cini E, Houvenaeghel G, Blache JL.

BMC Surg. 2017 Dec 28;17(1):136. doi: 10.1186/s12893-017-0332-9.

21.

Value of Diaphragmatic Surgery During Interval Debulking Surgery.

Pelissier A, Franke O, Darai E, Houvenaeghel G, Chereau E, Rouzier R.

Anticancer Res. 2018 Jan;38(1):411-416.

PMID:
29277802
22.

Sentinel lymph node biopsy validation for large tumors.

Houvenaeghel G, Quilichini O, Cohen M, Reyal F, Classe JM, Mazouni C, Giard S, Carrabin N, Charitansky H, Darai E, Hudry D, Azuar P, Villet R, Gimbergues P, Tunon-DE-Lara C, Lambaudie E.

Int J Surg. 2017 Dec;48:275-280. doi: 10.1016/j.ijsu.2017.10.077. Epub 2017 Nov 24.

23.

Prospective Assessment of First-Year Quality of Life After Pelvic Exenteration for Gynecologic Malignancy: A French Multicentric Study.

Martinez A, Filleron T, Rouanet P, Méeus P, Lambaudie E, Classe JM, Foucher F, Narducci F, Gouy S, Guyon F, Marchal F, Jouve E, Colombo PE, Mourregot A, Rivoire M, Chopin N, Houvenaeghel G, Jaffre I, Leveque J, Lavoue V, Leblanc E, Morice P, Stoeckle E, Verheaghe JL, Querleu D, Ferron G.

Ann Surg Oncol. 2018 Feb;25(2):535-541. doi: 10.1245/s10434-017-6120-z. Epub 2017 Nov 20.

PMID:
29159738
24.

Is post-mastectomy radiation therapy contributive in pN0-1mi breast cancer patients? Results of a French multi-centric cohort.

Forissier V, Tallet A, Cohen M, Classe JM, Reyal F, Chopin N, Mazouni C, Gimbergues P, Daraï E, Colombo PE, Azuar P, Lambaudie E, Houvenaeghel G.

Eur J Cancer. 2017 Dec;87:47-57. doi: 10.1016/j.ejca.2017.10.004. Epub 2017 Nov 3.

PMID:
29107861
25.

Similar response profile to neoadjuvant chemotherapy, but different survival, in inflammatory versus locally advanced breast cancers.

Monneur A, Goncalves A, Gilabert M, Finetti P, Tarpin C, Zemmour C, Extra JM, Tallet A, Lambaudie E, Jacquemier J, Houvenaeghel G, Boher JM, Viens P, Bertucci F.

Oncotarget. 2017 Jul 31;8(39):66019-66032. doi: 10.18632/oncotarget.19732. eCollection 2017 Sep 12.

26.

Adjuvant chemotherapy in pT1ab node-negative triple-negative breast carcinomas: Results of a national multi-institutional retrospective study.

de Nonneville A, Gonçalves A, Zemmour C, Cohen M, Classe JM, Reyal F, Colombo PE, Jouve E, Giard S, Barranger E, Sabatier R, Bertucci F, Boher JM, Houvenaeghel G.

Eur J Cancer. 2017 Oct;84:34-43. doi: 10.1016/j.ejca.2017.06.043. Epub 2017 Aug 4.

PMID:
28780480
27.

Radio-surgical and pathologic correlations of pelvic intravenous leiomyomatosis.

Jalaguier-Coudray A, Allain-Nicolai A, Thomassin-Piana J, Villard-Mahjoub R, Delarbre B, Rua S, Lambaudie E, Houvenaeghel G.

Abdom Radiol (NY). 2017 Dec;42(12):2927-2932. doi: 10.1007/s00261-017-1225-1.

PMID:
28643137
28.

Survival after breast cancer local recurrence according to therapeutic strategies.

Houvenaeghel G, Boher JM, Michel V, Bannier M, Minsat M, Tallet A, Cohen M, Buttarelli M, Resbeut M, Lambaudie E.

Eur J Surg Oncol. 2017 Aug;43(8):1409-1414. doi: 10.1016/j.ejso.2017.04.006. Epub 2017 May 4.

PMID:
28536053
29.

Therapeutic escalation - De-escalation: Data from 15.508 early breast cancer treated with upfront surgery and sentinel lymph node biopsy (SLNB).

Houvenaeghel G, Lambaudie E, Cohen M, Classe JM, Reyal F, Garbay JR, Giard S, Chopin N, Martinez A, Rouzier R, Daraï E, Colombo PE, Coutant C, Gimbergues P, Azuar P, Villet R, Tunon de Lara C, Barranger E, Sabiani L, Goncalves A.

Breast. 2017 Aug;34:24-33. doi: 10.1016/j.breast.2017.04.008. Epub 2017 May 3.

PMID:
28475932
30.

Quality of life after mastectomy with or without immediate breast reconstruction.

Dauplat J, Kwiatkowski F, Rouanet P, Delay E, Clough K, Verhaeghe JL, Raoust I, Houvenaeghel G, Lemasurier P, Thivat E, Pomel C; STIC-RMI working group.

Br J Surg. 2017 Aug;104(9):1197-1206. doi: 10.1002/bjs.10537. Epub 2017 Apr 12.

PMID:
28401542
31.

[Mastectomy in ambulatory hospitalization or 24hours: Feasibility, satisfaction and preferences of the patients].

Lobelle S, Raylet M, Cohen M, Lambaudie E, Bannier M, Blache JL, Francon D, Houvenaeghel G.

Gynecol Obstet Fertil Senol. 2017 Feb;45(2):89-94. doi: 10.1016/j.gofs.2016.12.020. Epub 2017 Feb 8. French.

PMID:
28368801
32.

Value of Dynamic Contrast-enhanced and Diffusion-weighted MR Imaging in the Detection of Pathologic Complete Response in Cervical Cancer after Neoadjuvant Therapy: A Retrospective Observational Study.

Jalaguier-Coudray A, Villard-Mahjoub R, Delouche A, Delarbre B, Lambaudie E, Houvenaeghel G, Minsat M, Tallet A, Sabatier R, Thomassin-Naggara I.

Radiology. 2017 Aug;284(2):432-442. doi: 10.1148/radiol.2017161299. Epub 2017 Mar 16.

PMID:
28301309
33.

[Impact of Her2 and BRCA1/2 status in high-dose chemotherapy and autologous stem cells transplantation in the treatment of breast cancer: The Institut Paoli Calmettes' experience].

Boudin L, Chabannon C, Sfumato P, Sabatier R, Bertucci F, Tarpin C, Provansal M, Houvenaeghel G, Lambaudie E, Tallet A, Resbeut M, Charafe-Jauffret E, Calmels B, Lemarie C, Boher JM, Extra JM, Viens P, Gonçalves A.

Bull Cancer. 2017 Apr;104(4):332-343. doi: 10.1016/j.bulcan.2016.12.007. Epub 2017 Feb 16. French.

PMID:
28214007
34.

Benefit of adjuvant chemotherapy with or without trastuzumab in pT1ab node-negative human epidermal growth factor receptor 2-positive breast carcinomas: results of a national multi-institutional study.

de Nonneville A, Gonçalves A, Zemmour C, Classe JM, Cohen M, Lambaudie E, Reyal F, Scherer C, Muracciole X, Colombo PE, Giard S, Rouzier R, Villet R, Chopin N, Darai E, Garbay JR, Gimbergues P, Sabiani L, Coutant C, Sabatier R, Bertucci F, Boher JM, Houvenaeghel G.

Breast Cancer Res Treat. 2017 Apr;162(2):307-316. doi: 10.1007/s10549-017-4136-5. Epub 2017 Feb 2.

PMID:
28155054
35.

Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation.

Boudin L, Gonçalves A, Sabatier R, Moretta J, Sfumato P, Asseeva P, Livon D, Bertucci F, Extra JM, Tarpin C, Houvenaeghel G, Lambaudie E, Tallet A, Resbeut M, Sobol H, Charafe-Jauffret E, Calmels B, Lemarie C, Boher JM, Viens P, Eisinger F, Chabannon C.

Bone Marrow Transplant. 2017 Mar;52(3):498. doi: 10.1038/bmt.2016.291. Epub 2017 Jan 16. No abstract available.

PMID:
28092355
36.

Pathological complete response in invasive breast cancer treated by skin sparing mastectomy and immediate reconstruction following neoadjuvant chemotherapy and radiation therapy: Comparison between immunohistochemical subtypes.

Barrou J, Bannier M, Cohen M, Lambaudie E, Gonçalves A, Bertrand P, Buttarelli M, Opinel P, Sterkers N, Tallet A, Zinzindohoué C, Houvenaeghel G.

Breast. 2017 Apr;32:37-43. doi: 10.1016/j.breast.2016.12.014. Epub 2016 Dec 26.

PMID:
28033508
37.

Impact of age on surgical staging and approaches (laparotomy, laparoscopy and robotic surgery) in endometrial cancer management.

Bourgin C, Lambaudie E, Houvenaeghel G, Foucher F, Levêque J, Lavoué V.

Eur J Surg Oncol. 2017 Apr;43(4):703-709. doi: 10.1016/j.ejso.2016.10.022. Epub 2016 Nov 27.

38.

Prognostic impact of hormone receptor- and HER2-defined subtypes in inflammatory breast cancer treated with high-dose chemotherapy: a retrospective study.

Boudin L, Gonçalves A, Sfumato P, Sabatier R, Bertucci F, Tarpin C, Provansal M, Houvenaeghel G, Lambaudie E, Tallet A, Resbeut M, Charafe-Jauffret E, Calmels B, Lemarie C, Boher JM, Extra JM, Viens P, Chabannon C.

J Cancer. 2016 Oct 23;7(14):2077-2084. eCollection 2016.

39.

Daily Practice Management of pT1a-b pN0 Breast Carcinoma: A Prospective French ODISSEE Cohort Study.

Dalenc F, Penault-Llorca F, Cohen M, Houvenaeghel G, Piat JM, Liegeois P, Puyuelo L, Suchaud JP, Zouai M, Lacroix-Triki M, Radosevic-Robin N, Benkanoun C, Attar-Rabia H, Chauvet MP, Gligorov J, Belkacemi Y.

Clin Breast Cancer. 2017 Apr;17(2):107-116. doi: 10.1016/j.clbc.2016.08.007. Epub 2016 Aug 31.

PMID:
27856201
40.

Exclusive intraoperative radiotherapy for invasive breast cancer in elderly patients (>70 years): proportion of eligible patients and local recurrence-free survival.

Lambaudie E, Houvenaeghel G, Ziouèche A, Knight S, Dravet F, Garbay JR, Giard S, Charitansky H, Cohen M, Faure C, Hudry D, Azuar P, Villet R, Gimbergues P, de Lara CT, Tallet A, Bannier M, Minsat M, Resbeut M.

BMC Surg. 2016 Nov 15;16(1):74.

41.

Axillary lymph node micrometastases decrease triple-negative early breast cancer survival.

Houvenaeghel G, Sabatier R, Reyal F, Classe JM, Giard S, Charitansky H, Rouzier R, Faure C, Garbay JR, Daraï E, Hudry D, Gimbergues P, Villet R, Lambaudie E.

Br J Cancer. 2016 Oct 25;115(9):1024-1031. doi: 10.1038/bjc.2016.283. Epub 2016 Sep 29.

42.

[Single-port versus mini-laparoscopy in benign adnexal surgery: Results of a not randomized pilot study].

Peretti V, Chereau E, Lambaudie E, Greco F, Butarelli M, Jauffret C, Rua-Ribeiro S, Houvenaeghel G.

Gynecol Obstet Fertil. 2016 Nov;44(11):620-628. doi: 10.1016/j.gyobfe.2016.08.005. Epub 2016 Oct 15. French.

PMID:
27751747
43.

Corrigendum to "Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation" [Eur J Cancer 57 (April 2016) 118-126].

Boudin L, Chabannon C, Sfumato P, Sabatier R, Bertucci F, Tarpin C, Provansal M, Houvenaeghel G, Lambaudie E, Tallet A, Resbeut M, Charafe-Jauffret E, Calmels B, Lemarie C, Boher JM, Extra JM, Viens P, Gonçalves A.

Eur J Cancer. 2016 Nov;67:223. doi: 10.1016/j.ejca.2016.09.002. Epub 2016 Sep 24. No abstract available.

PMID:
27680408
44.

Impact of completion axillary lymph node dissection in patients with breast cancer and isolated tumour cells or micrometastases in sentinel nodes.

Houvenaeghel G, Boher JM, Reyal F, Cohen M, Garbay JR, Classe JM, Rouzier R, Giard S, Faure C, Charitansky H, Tunon de Lara C, Daraï E, Hudry D, Azuar P, Gimbergues P, Villet R, Sfumato P, Lambaudie E.

Eur J Cancer. 2016 Nov;67:106-118. doi: 10.1016/j.ejca.2016.08.003. Epub 2016 Sep 16.

PMID:
27640137
45.

Pour une désescalade chirurgicale dans le traitement des cancers infiltrant du sein.

Houvenaeghel G, Cohen M, Bannier M, Jauffret C, Buttarelli M, Lambaudie E.

Bull Cancer. 2016 Jun;103(6 Suppl 1):S92-5. doi: 10.1016/S0007-4551(16)30151-5. French.

PMID:
27494980
46.

Breast cancer in young women: Pathologic features and molecular phenotype.

Sabiani L, Houvenaeghel G, Heinemann M, Reyal F, Classe JM, Cohen M, Garbay JR, Giard S, Charitansky H, Chopin N, Rouzier R, Daraï E, Coutant C, Azuar P, Gimbergues P, Villet R, Tunon de Lara C, Lambaudie E.

Breast. 2016 Oct;29:109-16. doi: 10.1016/j.breast.2016.07.007. Epub 2016 Jul 29.

PMID:
27479041
47.

Evaluation of sentinel lymph node biopsy after previous breast surgery for breast cancer: GATA study.

Renaudeau C, Lefebvre-Lacoeuille C, Campion L, Dravet F, Descamps P, Ferron G, Houvenaeghel G, Giard S, Tunon de Lara C, Dupré PF, Fritel X, Ngô C, Verhaeghe JL, Faure C, Mezzadri M, Damey C, Classe JM.

Breast. 2016 Aug;28:54-9. doi: 10.1016/j.breast.2016.04.006. Epub 2016 May 20.

PMID:
27214241
48.

Locoregional treatment of early breast cancer with isolated tumor cells or micrometastases on sentinel lymph node biopsy.

Tallet A, Lambaudie E, Cohen M, Minsat M, Bannier M, Resbeut M, Houvenaeghel G.

World J Clin Oncol. 2016 Apr 10;7(2):243-52. doi: 10.5306/wjco.v7.i2.243. Review.

49.

Is breast conservative surgery a reasonable option in multifocal or multicentric tumors?

Houvenaeghel G, Tallet A, Jalaguier-Coudray A, Cohen M, Bannier M, Jauffret-Fara C, Lambaudie E.

World J Clin Oncol. 2016 Apr 10;7(2):234-42. doi: 10.5306/wjco.v7.i2.234. Review.

50.

Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation.

Boudin L, Gonçalves A, Sabatier R, Moretta J, Sfumato P, Asseeva P, Livon D, Bertucci F, Extra JM, Tarpin C, Houvenaeghel G, Lambaudie E, Tallet A, Resbeut M, Sobol H, Charafe-Jauffret E, Calmels B, Lemarie C, Boher JM, Viens P, Eisinger F, Chabannon C.

Bone Marrow Transplant. 2016 Aug;51(8):1082-6. doi: 10.1038/bmt.2016.82. Epub 2016 Apr 4. Erratum in: Bone Marrow Transplant. 2017 Mar;52(3):498.

PMID:
27042835

Supplemental Content

Loading ...
Support Center